Why sponsors trust us as their research partner
Nivinta is the exclusive research partner of Ocean Skin and Vein Institute (OSVI), a leading dermatology practice. This collaboration, led by renowned principal investigator Dr. Divya Shokeen, and Meera Parikh, who brings over 15 years of clinical research experience, ensures that Nivinta's clinical sites uphold regulatory compliance and data integrity, while delivering clinical trials that exceed sponsor expectations.
We are currently looking to expand research activities at OSVI’s Manhattan Beach location.
Our Approach
-
At Ocean Skin and Vein Institute (OSVI), our highly qualified team utilizes modern infrastructure and advanced equipment to support clinical trials effectively. OSVI's state-of-the-art imaging devices, including dermatoscopes and high-resolution cameras, allow for precise measurements and documentation. Well-equipped treatment rooms and diagnostic tools enable efficient evaluation, while robust data management systems that ensures accurate tracking of patient information and trial progress. This combination creates an optimal environment for successful clinical research and improved patient outcomes.
-
Patient monitoring and safety is our highest priority. This involves continuous assessment of patients' health status and closely tracking any known and unknown adverse events. Our team leverages an effective patient monitoring system which includes regular check-ins, reviewing health data prior to study visits, robust communication and maintaining current patients informed consents.
-
Ensuring data accuracy is vital for maintaining the integrity of study results. This involves meticulous data collection, regular verification, and internal audits. Nivinta also prioritizes robust training for our research team to enhance data reliability and integrity.
-
To ensure successful study execution, Nivinta develops detailed site operating procedures that streamline site activation, patient recruitment, and regulatory compliance. Our team focuses on maintaining trial timelines, reducing costs while upholding high standards.